全文获取类型
| 收费全文 | 16268篇 |
| 免费 | 1708篇 |
| 国内免费 | 703篇 |
专业分类
| 耳鼻咽喉 | 224篇 |
| 儿科学 | 324篇 |
| 妇产科学 | 348篇 |
| 基础医学 | 1832篇 |
| 口腔科学 | 661篇 |
| 临床医学 | 1829篇 |
| 内科学 | 2424篇 |
| 皮肤病学 | 195篇 |
| 神经病学 | 972篇 |
| 特种医学 | 562篇 |
| 外国民族医学 | 3篇 |
| 外科学 | 2112篇 |
| 综合类 | 2099篇 |
| 现状与发展 | 1篇 |
| 一般理论 | 1篇 |
| 预防医学 | 1186篇 |
| 眼科学 | 369篇 |
| 药学 | 1598篇 |
| 6篇 | |
| 中国医学 | 693篇 |
| 肿瘤学 | 1240篇 |
出版年
| 2024年 | 24篇 |
| 2023年 | 165篇 |
| 2022年 | 381篇 |
| 2021年 | 570篇 |
| 2020年 | 421篇 |
| 2019年 | 514篇 |
| 2018年 | 545篇 |
| 2017年 | 482篇 |
| 2016年 | 482篇 |
| 2015年 | 749篇 |
| 2014年 | 927篇 |
| 2013年 | 1038篇 |
| 2012年 | 1342篇 |
| 2011年 | 1509篇 |
| 2010年 | 1133篇 |
| 2009年 | 889篇 |
| 2008年 | 1126篇 |
| 2007年 | 1036篇 |
| 2006年 | 999篇 |
| 2005年 | 827篇 |
| 2004年 | 647篇 |
| 2003年 | 519篇 |
| 2002年 | 403篇 |
| 2001年 | 261篇 |
| 2000年 | 241篇 |
| 1999年 | 200篇 |
| 1998年 | 123篇 |
| 1997年 | 126篇 |
| 1996年 | 102篇 |
| 1995年 | 70篇 |
| 1994年 | 80篇 |
| 1993年 | 78篇 |
| 1992年 | 86篇 |
| 1991年 | 95篇 |
| 1990年 | 88篇 |
| 1989年 | 77篇 |
| 1988年 | 60篇 |
| 1987年 | 50篇 |
| 1986年 | 39篇 |
| 1985年 | 25篇 |
| 1984年 | 24篇 |
| 1983年 | 16篇 |
| 1982年 | 9篇 |
| 1981年 | 13篇 |
| 1980年 | 14篇 |
| 1979年 | 12篇 |
| 1978年 | 8篇 |
| 1977年 | 13篇 |
| 1975年 | 6篇 |
| 1974年 | 6篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
2.
3.
A mixed‐method study of effects of a therapeutic play intervention for children on parental anxiety and parents' perceptions of the intervention 
下载免费PDF全文
下载免费PDF全文 4.
Jae Eun Choi Tyler Werbel Zhenping Wang Chia Chi Wu Tony L. Yaksh Anna Di Nardo 《Journal of dermatological science》2019,93(1):58-64
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献5.
Fur-Hsing Wen Jen-Shi Chen Wen-Chi Chou Wen-Cheng Chang Wen Chi Shen Chia-Hsun Hsieh Siew Tzuh Tang 《Journal of pain and symptom management》2019,57(1):64-72
Context
Family caregivers constitute a critical component of the end-of-life care system with considerable cost to themselves. However, the joint association of terminally ill cancer patients' symptom distress and functional impairment with caregivers' subjective caregiving burden, quality of life (QOL), and depressive symptoms remains unknown.Objectives/Methods
We used multivariate hierarchical linear modeling to simultaneously evaluate associations between five distinct patterns of conjoint symptom distress and functional impairment (symptom-functional states) and subjective caregiving burden, QOL, and depressive symptoms in a convenience sample of 215 family caregiver–patient dyads. Data were collected every 2 to 4 weeks over patients' last 6 months.Results
Caregivers of patients in the worst symptom-functional states (States 3–5) reported worse subjective caregiving burden and depressive symptoms than those in the best two states, but the three outcomes did not differ between caregivers of patients in State 3 and States 4–5. Caregivers of patients in State 5 endured worse subjective caregiving burden and QOL than those in State 4. Caregivers of patients in State 4 suffered worse subjective caregiving burden and depressive symptoms but comparable QOL to those in State 2.Conclusion
Patients' five distinct, conjoint symptom-functional states were significantly and differentially associated with their caregivers' worse subjective caregiving burden, QOL, and depressive symptoms while caring for patients over their last 6 months. 相似文献6.
7.
8.
目的探讨不同时期婴幼儿口腔颌面部血管瘤TRAIL受体DR4、DR5 m RNA的表达及意义。方法本研究于2013年3—10月在中国医科大学中心实验室完成。收集婴幼儿口腔颌面部血管瘤组织标本40例(增殖期血管瘤26例、退化期血管瘤14例),以及正常皮肤组织标本12例,应用RT-PCR检测TRAIL的2个受体DR4和DR5m RNA在其中的分布情况。结果增殖期血管瘤组织中DR4和DR5 m RNA的表达强度显著低于退化期血管瘤和正常皮肤组织,差异有统计学意义(P<0.01)。退化期血管瘤和正常皮肤组织中DR4、DR5 m RNA的表达强度较高,但二者之间差异无统计学意义。结论退化期血管瘤组织DR4和DR5 m RNA表达程度高,与增殖期血管瘤相比,退化期血管瘤可以更多的结合TRAIL,细胞凋亡增多,引发血管瘤消退。 相似文献
9.
10.